Psychedelic Business Spotlight – February 25
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
psychedelic investor
How Long Until Psychedelic Stocks Payoff?
Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing in psychedelic stocks.
Cathie Wood’s ARK Genomic Revolution ETF Buys Psychedelic Stock
Our resident Psychedelic Investor explains why this is an important moment for the psychedelics sector.
End of content
End of content